The vaccines which are listed in World Health Organization's (WHO) emergency use listing will also be granted emergency use approval in India.

Over 91.15% of patients treated with PegIFN were found to be RT PCR negative by day 7 as compared to 78.90 per cent on the 'standard of care' arm; PegIFN reduced the duration for supplemental oxygen to 56 hours from 84 hours in moderate COVID-19 patients

Stock Market News Updates Today: Bajaj Finserv, IndusInd Bank, RIL, Kotak Bank were among the top gainers today, while NTPC, PowerGrid, Asian Paints, ICICI Bank, Tata Motors were among the top losers

Stock Market News Updates Today: Earlier today, Sensex hit a record high of 51,804 and Nifty hit a lifetime high of 15,243

Stock Market News Updates Today: RIL, Bajaj twins, Airtel were among the top gainers while, Nestle, TCS, Axis Bank, L&T traded as the top losers

The research, published in the journal Nature Medicine, noted that the vaccine is effective against coronavirus variants carrying the N501Y and E484K mutations

Fact sheets for recipients of Moderna and Pfizer-BioNTech vaccines in US and UK clarify that the vaccines are yet to be fully approved; recipients have been asked to get help if they experience severe side effects or allergic reactions

Barring realty and auto sectors, all indices closed in bullish territory, with over 2% gain in media, 1.7% rise in PSU Bank and 1.3% rise in metal stocks

India Stock Market Highlights Today: ONGC followed by Tata Steel, L&T, Sun Pharma, M&M, ICICI Bank and NTPC were among the top gainers in the Sensex pack

Though Pfizer India says it remains committed to advance dialogue with Indian government to make the vaccine available for use, experts believe it will be difficult for its parent to supply adequate quantities of the vaccine

India Stock Market Highlights Today: UltraTech Cement followed by Tata Steel, ONGC, IndusInd Bank, HDFC Bank, M&M, Infosys and Reliance Industries were among the top losers in the Sensex pack. On the other hand, Maruti, Nestle India, Titan and PowerGrid were among the gainers

India Stock Market Highlights Today: Intraday, both indices touched all time highs today, with Sensex hitting 46,164 and Nifty touching 13,548.

The company is also working with the USFDA to start an Investigational New Drug (IND) application for Pegylated Interferon alpha-2b in order to initiate clinical trials in US

India Stock Market Highlights Today: During the session, Sensex touched a lifetime high of 45,148 and Nifty hit an all-time high of 13,280

Primary efficacy analysis of the Phase 3 COVE study of Moderna' COVID-19 vaccine involved 30,000 participants included 196 cases of COVID-19, of which 30 cases were severe

India Stock Market Highlights Today: Global equities were mostly buoyed today encouraged by news on the development of coronavirus vaccines and more assurance for a transition of power in the US to President-elect Joe Biden

Centre is worried about the caseload surge in urban centres, which has resulted in the enforcement of measures such as curfews by state governments.

The study found that patients of confirmed COVID-19 with moderate symptoms were discharged from hospital earlier than those patients that did not receive Favipiravir, with the median time to clinical cure reduced by 2.5 days compared with the control group.

USFDA Commissioner Stephen Hahn said that USFDA has been preparing for review of EUAs for COVID-19 vaccines for the past several months and requests will be processed \"as expeditiously as possible\"

COVID 19-driven reforms can raise India's medium-term growth; US President-elect Joe Biden has said he wants to make sure that China plays by the rules and announced that his administration will rejoin the World Health Organisation; Pfizer approaches USFDA to secure emergency use authorisation for COVID vaccine. Watch this and more news on News Blast.